Table 2.
Chr | Start | End | dbSNP | Ref | Alt | Gene | Transcript | Exon | Codon change | Amino acid change | Impact | Max_aaf_all (%) | ToMMoaaf (%) | CADD | Cbll |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
15 | 41,555,002 | 41,555,003 | – | C | T | CHP1 | NM_007236.4 | 4/7 | c.271C > T | p.R91C | missense | – | – | 32.0 | 30.08 |
6 | 31,935,498 | 31,935,499 | rs765832592 | C | T | SKIV2L | NM_006929.4 | 22/28 | c.2591C > T | p.S864L | missense | 0.059 | 0.050 | 17.6 | 44.13 |
6 | 32,148,942 | 32,148,943 | – | C | T | AGER | NM_001206929.1.3 | 11/11 | c.1240G > A | p.E414K | missense | – | 0.010 | 12.1 | 26.89 |
15 | 34,048,529 | 34,048,530 | rs766762265 | A | G | RYR3 | NM_001036.4 | 59/104 | c.8539A > G | p.T2847A | missense | 0.307 | 0.170 | 9.7 | 4.68 |
6 | 27,368,455 | 27,368,456 | rs749223275 | T | G | ZNF391 | NM_001076781.2 | 3/3 | c.307 T > G | p.F103V | missense | 0.058 | 0.040 | 8.7 | 4.63 |
15 | 43,816,412 | 43,816,413 | rs201851388 | C | A | MAP1A | NM_002373.5 | 4/6 | c.2742C > A | p.D914E | missense | 0.255 | 0.270 | 8.0 | 136.43 |
6 | 28,253,358 | 28,253,359 | rs760010326 | A | C | PGBD1 | NM_001184743.1 | 3/7 | c.428A > C | p.H143P | missense | 0.058 | 0.040 | 5.1 | 17.49 |
Seven segregated candidate variants causing protein alteration and showing a low allele frequency of < 1% and gene expression > 1 median transcripts per kilobase million (TPM) in the cerebellum. Variants are ordered according to the CADD score. None of the other six candidates except for CHP1 mutation demonstrated a causal link to ARCAs. Therefore, we considered that the novel homozygous missense variant CHP1 p.Arg91Cys had been responsible for the ataxic phenotype of the two present cases. Variants were annotated using snpEff 4.3i and gemini 0.19.1. The genomic positions of the variants are based on hg19, and Start and End represent the 0-based and 1-based genomic position, respectively. Impact shows the biological consequence of the most severely affected transcript. Max_aaf_all shows the maximum alternate allele frequency in each population from the 1000 Genomes Project, Exome Sequencing Project, or Exome Aggregation Consortium. ToMMo aaf shows the alternate allele frequency in 3554 Japanese whole genomes obtained from Tohoku University Tohoku Medical Megabank Organization. CADD shows the PHRED-like scaled scores of predictive deleteriousness, and typically scores of 10 or higher indicate possibly pathogenic variants. The column labeled Cbll represents the amount of gene expression in the cerebellum based on GTEx Portal V8. The values show the median TPM